PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.\', \'Department of Internal Medicine, National Yang-Ming University Hospital, Yilan, Taiwan, ROC.\', \'Division of Nephrology, Department of Internal Medicine, Taipei City Hospital, Heping Fuyou Branch, Taipei, Taiwan, ROC.\', \'Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital Fenglin Branch, Hualien, Taiwan, ROC.\', \'Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.\', \'Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.\', \'Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan, ROC.\', \'Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.\', \'Faculty of Pharmacy, National Yang-Ming University, Taipei, Taiwan, ROC.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/JCMA.0000000000000354
?:hasPublicationType
?:journal
  • Journal of the Chinese Medical Association : JCMA
is ?:pmid of
?:pmid
?:pmid
  • 32433344
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Judicious use of sodium-glucose cotransporter 2 inhibitors in patients with diabetes on coronavirus-19 pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all